CONJUPRI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Conjupri, and when can generic versions of Conjupri launch?
Conjupri is a drug marketed by Cspc Ouyi and is included in one NDA.
The generic ingredient in CONJUPRI is levamlodipine maleate. One supplier is listed for this compound. Additional details are available on the levamlodipine maleate profile page.
Summary for CONJUPRI
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 4 |
What excipients (inactive ingredients) are in CONJUPRI? | CONJUPRI excipients list |
DailyMed Link: | CONJUPRI at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CONJUPRI
US Patents and Regulatory Information for CONJUPRI
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cspc Ouyi | CONJUPRI | levamlodipine maleate | TABLET;ORAL | 212895-001 | Dec 19, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cspc Ouyi | CONJUPRI | levamlodipine maleate | TABLET;ORAL | 212895-002 | Dec 19, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cspc Ouyi | CONJUPRI | levamlodipine maleate | TABLET;ORAL | 212895-003 | Dec 19, 2019 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |